Development of vaccines at the time of COVID-19 | Zendy

Jeffrey Almond | Zendy; Jörg Hacker | Zendy; Colin R. Harwood | Zendy; Mariagrazia Pizza | Zendy; Rino Rappuoli | Zendy; Eliora Z. Ron | Zendy; Philippe Sansonetti | Zendy; Samantha Vanderslott | Zendy; Lothar H. Wieler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Development of vaccines at the time of COVID-19

Author(s) -

Jeffrey Almond,

Jörg Hacker,

Colin R. Harwood,

Mariagrazia Pizza,

Rino Rappuoli,

Eliora Z. Ron,

Philippe Sansonetti,

Samantha Vanderslott,

Lothar H. Wieler

Publication year - 2020

Publication title -

microlife

Language(s) - English

Resource type - Journals

ISSN - 2633-6693

DOI - 10.1093/femsml/uqaa003

Subject(s) - covid-19 , pandemic , hacker , german , political science , vaccination , virology , public relations , engineering ethics , medicine , geography , engineering , computer science , outbreak , computer security , infectious disease (medical specialty) , disease , archaeology , pathology

In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Following the rapid and unpredicted spread of COVID-19 in the first seven months of 2020, the need to develop vaccines for pandemic viruses rapidly has been clearly established. Thus, this paper will concentrate on points that were highlighted by the recent COVID-19 pandemic and lessons learnt therefrom.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research